PDB Information

PDB3PE2
MethodX-RAY DIFFRACTION
Host OrganismEscherichia coli
Gene SourceHomo sapiens
Primary Citation
Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical trials for the treatment of cancer.
Battistutta, R., Cozza, G., Pierre, F., Papinutto, E., Lolli, G., Sarno, S., O'Brien, S.E., Siddiqui-Jain, A., Haddach, M., Anderes, K., Ryckman, D.M., Meggio, F., Pinna, L.A.
Biochemistry
HeaderTransferase/Transferase Inhibitor
Released2010-10-25
Resolution1.900
CATH Insert Date11 Sep, 2011

PDB Images (4)

PDB Prints

PDB Chains (1)

Chain ID Date inserted into CATH CATH Status
A 12 Sep, 2011 Chopped

CATH Domains (2)

Domain ID Date inserted into CATH Superfamily CATH Status
3pe2A01 16 Sep, 2011 1.10.510.10 Assigned
3pe2A02 16 Sep, 2011 3.30.200.20 Assigned

UniProtKB Entries (1)

Accession Gene ID Taxon Description
P68400 CSK21_HUMAN Homo sapiens Casein kinase II subunit alpha
CATH-Gene3D is a Global Biodata Core Resource Learn more...